Ravi Rasendra Mazumdar
Director/Board Member chez BIOCON LIMITED
Fortune : 17 M $ au 31/03/2024
Profil
Ravi Rasendra Mazumdar is currently serving as a Non-Independent Non-Executive Director at Biocon Ltd.
since 2011.
He is also a Director at Glentec International and Biocon Biologics Uk Ltd.
Additionally, he holds the position of Professor at The University of Waterloo and the Indian Institute of Science.
In his former roles, Dr. Mazumdar has worked as a Director at Clinigene International Ltd., Principal at Macrovision Corp., Vice President-Engineering at 98th Street Ventures, Inc., and Professor at The Trustees of Columbia University in The City of New York, McGill University, Purdue University, the University of Essex, and INRS University.
Dr. Mazumdar completed his graduate degree from Imperial College London in 1978.
He obtained his doctorate degree from the University of California, Los Angeles in 1983.
He also holds an undergraduate degree from the Indian Institute of Technology Bombay, which he received in 1977.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOCON LIMITED
0,44% | 23/12/2023 | 5 301 321 ( 0,44% ) | 17 M $ | 31/03/2024 |
| 30/06/2023 | 8 806 ( 0,00% ) | 74 089 $ | 31/03/2024 |
Postes actifs de Ravi Rasendra Mazumdar
| Sociétés | Poste | Début |
|---|---|---|
| BIOCON LIMITED | Director/Board Member | 01/01/2000 |
| The University of Waterloo | Corporate Officer/Principal | 06/09/2011 |
| Indian Institute of Science | Corporate Officer/Principal | 06/09/2011 |
| Glentec International | Director/Board Member | 06/09/2011 |
Biocon Biologics Uk Ltd.
 Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | Director/Board Member | 19/01/2021 |
Anciens postes connus de Ravi Rasendra Mazumdar
| Sociétés | Poste | Fin |
|---|---|---|
| INRS University | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
| University of Essex | Corporate Officer/Principal | - |
| Purdue University | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Ravi Rasendra Mazumdar
| Imperial College London | Graduate Degree |
| University of California, Los Angeles | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOCON LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Macrovision Corp.
 Macrovision Corp. Information Technology ServicesTechnology Services Macrovision Corp., provides software and entertainment technology services. It provides services to content owners, software and hardware vendors. It was founded in the year 1983. The company headquaters is located at California. | Technology Services |
98th Street Ventures, Inc.
 98th Street Ventures, Inc. Packaged SoftwareTechnology Services 98th Street Ventures, Inc. develops software for mobile Internet devices. The company was founded by Frank A. O'Donnell, Roger P.Hickey and Paul J. Duggan in 2003 and is headquartered in Evergreen Park, IL. | Technology Services |
| Glentec International | |
Clinigene International Ltd.
 Clinigene International Ltd. Medical/Nursing ServicesHealth Services Clinigene International Ltd. provided clinical research services. The company is headquartered in Bangalore, India. | Health Services |
Biocon Biologics Uk Ltd.
Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | Commercial Services |
